CN104740713A - Implantable biological energy insulin pump - Google Patents
Implantable biological energy insulin pump Download PDFInfo
- Publication number
- CN104740713A CN104740713A CN201310731830.7A CN201310731830A CN104740713A CN 104740713 A CN104740713 A CN 104740713A CN 201310731830 A CN201310731830 A CN 201310731830A CN 104740713 A CN104740713 A CN 104740713A
- Authority
- CN
- China
- Prior art keywords
- power generation
- implantable
- bioenergy
- layer
- insulin pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims abstract description 90
- 102000004877 Insulin Human genes 0.000 title claims abstract description 45
- 108090001061 Insulin Proteins 0.000 title claims abstract description 45
- 229940125396 insulin Drugs 0.000 title claims abstract description 45
- 238000010248 power generation Methods 0.000 claims abstract description 48
- 210000000709 aorta Anatomy 0.000 claims abstract description 34
- 238000004146 energy storage Methods 0.000 claims abstract description 21
- 239000008280 blood Substances 0.000 claims abstract description 19
- 210000004369 blood Anatomy 0.000 claims abstract description 19
- 238000002347 injection Methods 0.000 claims abstract description 13
- 239000007924 injection Substances 0.000 claims abstract description 13
- 238000012544 monitoring process Methods 0.000 claims abstract description 13
- 238000005538 encapsulation Methods 0.000 claims abstract description 12
- 238000001802 infusion Methods 0.000 claims abstract description 5
- 230000001105 regulatory effect Effects 0.000 claims abstract description 5
- 239000010410 layer Substances 0.000 claims description 42
- 239000000463 material Substances 0.000 claims description 31
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 229910052719 titanium Inorganic materials 0.000 claims description 5
- 239000010936 titanium Substances 0.000 claims description 5
- 239000000919 ceramic Substances 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 229920005570 flexible polymer Polymers 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000003990 capacitor Substances 0.000 claims description 2
- 239000012774 insulation material Substances 0.000 claims description 2
- 239000002356 single layer Substances 0.000 claims description 2
- 230000008054 signal transmission Effects 0.000 claims 1
- 238000002513 implantation Methods 0.000 abstract description 4
- 238000010586 diagram Methods 0.000 description 7
- 238000004026 adhesive bonding Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000011810 insulating material Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000003683 cardiac damage Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000005674 electromagnetic induction Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14212—Pumping with an aspiration and an expulsion action
- A61M5/14216—Reciprocating piston type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0272—Electro-active or magneto-active materials
- A61M2205/0294—Piezoelectric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/04—General characteristics of the apparatus implanted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
Abstract
本发明提供一种植入式生物能胰岛素泵,包括血糖监测部、胰岛素注射泵、输注导管、控制部、信号发射部、体外通讯器以及发电部。发电部包括发电主体、调节端、输出电极、封装层以及电能存储部。其中,发电主体用于采集主动脉扩张时所产生的机械能,并转化为电能。发电主体为多层薄膜结构,包括位于中心层的压电层,以及位于压电层两侧的第一电极层和第二电极层。封装层覆盖于发电主体、调节端、输出电极以及电能存储单元的表面。调节端位于发电主体的两端,用于调节发电主体的长度。输出电极用于将电能输送给电能存储部。本发明的植入式生物能胰岛素泵无需更换电池,一次植入后可终身使用。
The invention provides an implantable bioenergy insulin pump, which includes a blood sugar monitoring part, an insulin injection pump, an infusion catheter, a control part, a signal transmitting part, an external communicator and a power generation part. The power generation part includes a power generation main body, a regulating terminal, an output electrode, an encapsulation layer and an electric energy storage part. Among them, the power generation main body is used to collect the mechanical energy generated when the aorta expands, and convert it into electrical energy. The main body of power generation is a multi-layer film structure, including a piezoelectric layer located in the center layer, and a first electrode layer and a second electrode layer located on both sides of the piezoelectric layer. The encapsulation layer covers the surfaces of the power generating body, the regulating terminal, the output electrodes and the electric energy storage unit. The adjustment ends are located at both ends of the power generation body and are used to adjust the length of the power generation body. The output electrodes are used to deliver electrical energy to the electrical energy storage. The implantable bioenergy insulin pump of the present invention does not need to replace batteries, and can be used for a lifetime after implantation once.
Description
技术领域technical field
本发明涉及一种植入式胰岛素泵,属于医疗器械领域。The invention relates to an implanted insulin pump, which belongs to the field of medical devices.
背景技术Background technique
糖尿病是中老年患者的常见病和多发病,作为一种终身性疾病,目前尚缺少彻底根治的治疗手段。对于严重的糖尿病患者,通常需要采取强化胰岛素治疗。由于强化治疗需要每日3次甚至更多次的注射胰岛素,大大增加了发生低血糖的风险和体重上升的可能性。Diabetes is a common and frequently-occurring disease in middle-aged and elderly patients. As a life-long disease, there is still a lack of radical treatment. In people with severe diabetes, intensive insulin therapy is usually required. Since intensive treatment requires 3 or more daily insulin injections, the risk of hypoglycemia and the possibility of weight gain are greatly increased.
近年来研发或临床试验中的植入式胰岛素泵有利于持续、平稳的控制血糖,并减少糖尿病相关的并发症。然而,植入式胰岛素泵作为一种体内植入的电子设备,需要持续的电能供应。而现有的微型电池的供电时间普遍较短,植入后一旦电池能量耗竭,就需要再次手术更换电池。这既会给患者造成生理上的痛苦以及心理上的恐惧和焦虑,还会增加患者及其家庭的经济负担。Implantable insulin pumps developed or in clinical trials in recent years are conducive to continuous and stable blood sugar control and reduce diabetes-related complications. However, an implantable insulin pump, as an electronic device implanted in the body, requires a continuous power supply. However, the power supply time of existing micro-batteries is generally short, and once the energy of the batteries is exhausted after implantation, another operation is required to replace the batteries. This will not only cause physical pain and psychological fear and anxiety to patients, but also increase the financial burden on patients and their families.
在人体内部,心脏的收缩运动和血液的流动都具有稳定和不间断的动能。如果能够采集其中一小部分动能并转化为电能,将有望成为植入式胰岛素泵的理想能量来源。然而,由于心脏是人体的“发动机”,不恰当的采集心脏动能必然会影响心脏的功能,甚至导致心脏损伤。此外,传统的基于法拉第定律的电磁感应式发电机体积较大、结构复杂,不适合体内植入。Inside the human body, both the contraction of the heart and the flow of blood have steady and uninterrupted kinetic energy. If a small part of the kinetic energy can be harvested and converted into electrical energy, it is expected to become an ideal energy source for implantable insulin pumps. However, since the heart is the "engine" of the human body, improper collection of cardiac kinetic energy will inevitably affect the function of the heart and even cause heart damage. In addition, traditional electromagnetic induction generators based on Faraday's law are large in size and complex in structure, and are not suitable for implantation in vivo.
发明内容Contents of the invention
为解决上述问题,本发明提供一种可植入体内并间接利用心脏生物能供电的植入式胰岛素泵,其特征在于,包括血糖监测部、胰岛素注射泵、输注导管、控制所述注射泵运行的控制部、信号发射部、用于接收信号的体外通讯器以及提供电能的发电部。其中,发电部包括发电主体、调节端、输出电极、电能存储单元以及封装层。其中,发电主体用于包绕主动脉,以采集主动脉扩张时所产生的机械能,并转化为电能。发电主体为多层薄膜结构,包括位于中心层的压电材料层,以及分别位于压电材料层两侧的第一电极层和第二电极层。调节端位于发电主体的两端,用于调节发电主体的长度。输出电极用于将电能输送给电能存储单元。电能存储单元用于存储电能并为血糖监测部、控制部、胰岛素注射泵和信号发射部供电。封装层覆盖于发电主体、调节端、输出电极以及电能存储单元的表面。In order to solve the above problems, the present invention provides an implantable insulin pump that can be implanted in the body and indirectly uses the bioenergy of the heart to supply power, which is characterized in that it includes a blood glucose monitoring unit, an insulin injection pump, an infusion catheter, and a control unit for the injection pump. The control part for operation, the signal transmitting part, the external communicator for receiving signals, and the power generation part for providing electric energy. Wherein, the power generation part includes a power generation main body, an adjustment terminal, an output electrode, an electric energy storage unit, and an encapsulation layer. Wherein, the power generating body is used to surround the aorta, so as to collect the mechanical energy generated when the aorta expands, and convert it into electrical energy. The main body of power generation is a multi-layer film structure, including a piezoelectric material layer located in the central layer, and a first electrode layer and a second electrode layer located on both sides of the piezoelectric material layer. The adjustment ends are located at both ends of the power generation body and are used to adjust the length of the power generation body. The output electrodes are used to deliver electrical energy to the electrical energy storage unit. The electric energy storage unit is used for storing electric energy and supplying power for the blood sugar monitoring part, the control part, the insulin injection pump and the signal transmitting part. The encapsulation layer covers the surfaces of the power generation main body, the regulating terminal, the output electrodes and the electric energy storage unit.
另外,本发明的植入式生物能胰岛素泵还可以具有这样的特征:其中,压电材料层含有纳米级压电材料,纳米级压电材料为压电晶体、压电陶瓷和有机压电聚合物中的任意一种。In addition, the implantable bioenergy insulin pump of the present invention may also have the following features: wherein, the piezoelectric material layer contains nanoscale piezoelectric materials, and the nanoscale piezoelectric materials are piezoelectric crystals, piezoelectric ceramics, and organic piezoelectric polymers. any of the things.
另外,本发明的植入式生物能胰岛素泵还可以具有这样的特征:其中,压电晶体、压电陶瓷、有机压电聚合物可以为纳米级压电材料的单层或多层结构。In addition, the implantable bioenergy insulin pump of the present invention may also have the feature that the piezoelectric crystals, piezoelectric ceramics, and organic piezoelectric polymers may be single-layer or multi-layer structures of nanoscale piezoelectric materials.
另外,本发明的植入式生物能胰岛素泵还可以具有这样的特征:其中,所述电能存储部为微型可充电电池或电容。In addition, the implantable bioenergy insulin pump of the present invention may also have such a feature: wherein, the electric energy storage part is a micro-rechargeable battery or a capacitor.
另外,本发明的植入式生物能胰岛素泵还可以具有这样的特征:还包括,整流滤波电路,连接于电能存储单元和输出电极之间。In addition, the implantable bioenergy insulin pump of the present invention may also have the following features: it further includes a rectification and filtering circuit connected between the electric energy storage unit and the output electrodes.
另外,本发明的植入式生物能胰岛素泵还可以具有这样的特征:其中,调节端的固定方式使用手术线缝合、钛夹钳夹或粘合剂粘合中的任意一种。In addition, the implantable bioenergy insulin pump of the present invention may also have the feature that the adjustment end is fixed by any one of surgical thread suture, titanium clamp clip or adhesive bonding.
另外,本发明的植入式生物能胰岛素泵还可以具有这样的特征:其中,调节端的一端为单排的卡齿,该卡齿的尖端平滑且面向发电主体的外侧,调节端的另一端为卡槽,卡槽的内部一侧具有与卡齿相配合的齿槽,另一侧为平面,卡齿与卡槽相卡合。In addition, the implantable bioenergy insulin pump of the present invention may also have the following features: one end of the adjustment end is a single row of teeth, the tip of the teeth is smooth and faces the outside of the power generating body, and the other end of the adjustment end is a locking tooth. One side of the card slot has tooth grooves matched with the card teeth, and the other side is a plane, and the card teeth are engaged with the card slots.
另外,本发明的植入式生物能胰岛素泵还可以具有这样的特征:其中,所述封装层以生物相容性好的柔性高分子绝缘材料作为封装材料。In addition, the implantable bioenergy insulin pump of the present invention may also have the following feature: wherein, the encapsulation layer uses a flexible polymer insulation material with good biocompatibility as the encapsulation material.
另外,本发明的植入式生物能胰岛素泵还可以具有这样的特征:发电部对主动脉的压力小于140mmHg。In addition, the implantable bioenergy insulin pump of the present invention may also have the following feature: the pressure of the power generation part on the aorta is less than 140mmHg.
发明作用与效果Invention function and effect
本发明的植入式生物能胰岛素泵,通过植入纳米级压电材料以采集主动脉扩张时所产生的能量并转化为电能,作为其能量来源。因此只要心脏跳动,本发明即可利用患者自身的生物能提供电能,免去了使用电池作为电源的必要,解决了电池能量耗竭后通过手术更换电池的问题。The implantable bioenergy insulin pump of the present invention collects the energy generated when the aorta expands by implanting the nanoscale piezoelectric material and converts it into electrical energy as its energy source. Therefore, as long as the heart is beating, the present invention can use the patient's own biological energy to provide electric energy, eliminating the need to use batteries as power sources, and solving the problem of replacing batteries through surgery after the battery energy is exhausted.
由于本发明采用纳米级压电材料作为发电主体,不仅可以有效地将体内的生物能转化为电能,而且体积微小,更适合体内植入。Since the present invention uses nanoscale piezoelectric materials as the main body of power generation, it can not only effectively convert bioenergy in the body into electric energy, but also has a small volume and is more suitable for implantation in the body.
由于本发明采用了柔软的环形结构包绕于主动脉的外壁,且能够定量控制本系统对主动脉的压力,因此既可以高效、充分的采集主动脉扩张时所产生的机械能,又不会对心脏功能产生明显影响。Since the present invention adopts a soft annular structure to wrap around the outer wall of the aorta, and can quantitatively control the pressure of the system on the aorta, it can efficiently and fully collect the mechanical energy generated when the aorta expands without causing any damage to the aorta. Cardiac function is significantly affected.
此外,由于本发明采用生物相容性好的柔性高分子绝缘材料封装,因此既能将发电主体与体内环境隔离,还可将主动脉壁形变产生的压力有效的传导至压电材料。In addition, since the present invention is packaged with a flexible polymer insulating material with good biocompatibility, it can not only isolate the power generation body from the internal environment, but also effectively transmit the pressure generated by the deformation of the aortic wall to the piezoelectric material.
此外,利用发电主体两端的调节端可调整发电主体包绕主动脉的紧张度,从而可调节压电材料的形变程度及输出电量。又由于调节端内不含压电材料及电极层,因此使用手术缝线或钛夹固定时不会损坏发电主体的结构。In addition, the tension of the power generation body around the aorta can be adjusted by using the adjustment ends at both ends of the power generation body, so that the deformation degree of the piezoelectric material and the output power can be adjusted. And because the adjustment end does not contain piezoelectric materials and electrode layers, the structure of the power generation body will not be damaged when it is fixed with surgical sutures or titanium clips.
并且,由于本发明的发电主体位于主动脉外部,不与血液直接接触,因而不存在血栓形成以及中风(心肌梗塞或脑梗塞)的风险。Moreover, since the power generating body of the present invention is located outside the aorta and does not come into direct contact with blood, there is no risk of thrombus formation and stroke (myocardial infarction or cerebral infarction).
附图说明Description of drawings
图1是本发明实施例一的植入式生物能胰岛素泵的示意图;FIG. 1 is a schematic diagram of an implantable bioenergy insulin pump according to Embodiment 1 of the present invention;
图2是本发明实施例一的发电主体的示意图;Fig. 2 is a schematic diagram of a power generating body according to Embodiment 1 of the present invention;
图3是本发明实施例一的发电主体的内部结构剖面图;Fig. 3 is a cross-sectional view of the internal structure of the power generation main body of Embodiment 1 of the present invention;
图4是图3中发电主体A区域的局部放大图;Fig. 4 is a partial enlarged view of the region A of the main body of power generation in Fig. 3;
图5是本发明实施例一中发电主体安装于主动脉上的截面图;Fig. 5 is a cross-sectional view of the power generation body installed on the aorta in Embodiment 1 of the present invention;
图6是本发明实施例四中调节端为卡齿结构的示意图;以及Fig. 6 is a schematic diagram of the adjusting end in the fourth embodiment of the present invention having a locking tooth structure; and
图7是本发明的电路示意图。Fig. 7 is a schematic circuit diagram of the present invention.
具体实施方式Detailed ways
以下根据附图说明本发明的植入式生物能胰岛素泵的具体实施方式,The following describes the specific implementation of the implantable bioenergy insulin pump of the present invention according to the accompanying drawings,
<实施例一><Example 1>
图1是本发明实施例一的植入式生物能胰岛素泵的示意图。如图1所示,植入式生物能胰岛素泵100包括控制部19、信号发射部16、注射泵15、输注导管151、血糖监测部20以及发电部200,发电部200包括发电主体11、整流滤波电路12、输出电极14和电能存储部13。Fig. 1 is a schematic diagram of an implantable bioenergy insulin pump according to Embodiment 1 of the present invention. As shown in FIG. 1 , the implantable bioenergy insulin pump 100 includes a control unit 19, a signal transmitting unit 16, a syringe pump 15, an infusion catheter 151, a blood glucose monitoring unit 20, and a power generation unit 200. The power generation unit 200 includes a power generation body 11, A rectification filter circuit 12 , an output electrode 14 and an electric energy storage unit 13 .
发电主体11为有弹性的环形结构,能够环绕于主动脉18的周围,发电主体11内部具有压电材料,可利用主动脉的形变产生电能。发电主体11的输出电极14后连接了整流滤波电路12,使得发电主体11输出的电能变得稳定。电能存储单元13连接于整流滤波电路12之后,用于储存电能,并为生物能胰岛素泵100的血糖监测部20、控制部19、信号发射部16以及注射泵15供电。The power generating body 11 is an elastic annular structure, which can surround the aorta 18. The power generating body 11 has a piezoelectric material inside, which can generate electric energy by utilizing the deformation of the aorta. The output electrode 14 of the power generation main body 11 is connected with a rectification filter circuit 12, so that the electric energy output by the power generation main body 11 becomes stable. The electric energy storage unit 13 is connected behind the rectifying and filtering circuit 12 to store electric energy and provide power for the blood glucose monitoring part 20 , the control part 19 , the signal transmitting part 16 and the injection pump 15 of the bioenergy insulin pump 100 .
图2是本发明实施例一的发电主体的示意图。如图2所示,发电主体11的初始状态为开环的形状,在环形结构的两端各具有一个调节端23,安装在主动脉外壁时需要将两个调节端连接在一起。在发电主体11和调节端23的外表面覆盖有封装层22。发电主体上具有两根输出电极14,用于将发电主体11产生的电能输出。Fig. 2 is a schematic diagram of a power generating body according to Embodiment 1 of the present invention. As shown in FIG. 2 , the initial state of the power generating body 11 is an open loop shape, and there is an adjustment end 23 at both ends of the ring structure, and the two adjustment ends need to be connected together when installed on the outer wall of the aorta. The outer surfaces of the generating body 11 and the regulating end 23 are covered with an encapsulation layer 22 . The power generating body has two output electrodes 14 for outputting the electric energy generated by the power generating body 11 .
图3是本发明实施例的发电主体的内部结构剖面图,如图3所示,发电主体11的内部为多层薄膜结构,包括位于主体中心层的纳米级压电材料111,以及分别位于压电材料两侧的第一电极层112和第二电极层113。封装层22采用具有生物相容性的柔性高分子绝缘材料,覆盖于发电主体11以及输出电极14的表面,并向发电主体11的外侧延伸形成两侧各一个调节端23。Fig. 3 is a sectional view of the internal structure of the power generating body of the embodiment of the present invention. As shown in Fig. 3, the interior of the power generating body 11 is a multi-layer thin film structure, including a nanoscale piezoelectric material 111 located in the central layer of the main body, and piezoelectric The first electrode layer 112 and the second electrode layer 113 on both sides of the electrical material. The encapsulation layer 22 is made of biocompatible flexible polymer insulating material, covers the surface of the power generation body 11 and the output electrode 14 , and extends to the outside of the power generation body 11 to form an adjustment terminal 23 on each side.
图4是图3中发电主体A区域的局部放大图。如图4所示,位于发电主体11中心层的纳米级压电材料111,第一电极层112和第二电极层113采用金或银等导电率高的薄层材料制成,与纳米级压电材料111相连接。Fig. 4 is a partial enlarged view of the region A of the power generation body in Fig. 3 . As shown in Figure 4, the nano-scale piezoelectric material 111 located in the central layer of the power generation body 11, the first electrode layer 112 and the second electrode layer 113 are made of thin-layer materials with high conductivity such as gold or silver, and are compatible with the nano-scale piezoelectric material. Electrical material 111 is connected.
发电主体11在自然状态下为弯曲的环状结构,且其薄膜结构具有良好的弹性,因此能够柔顺的包绕主动脉。The power generating body 11 is a curved ring structure in a natural state, and its thin film structure has good elasticity, so it can wrap around the aorta softly.
在体内植入时,可以通过外科手术的方法将发电主体11植入到主动脉周围并包绕主动脉。再通过调整调节端23使得发电主体11与主动脉的外壁紧密贴合,以采集主动脉形变所产生的能量。When implanted in the body, the power generating body 11 can be implanted around the aorta and surround the aorta by surgical methods. Then, by adjusting the adjusting end 23, the power generating body 11 is in close contact with the outer wall of the aorta, so as to collect the energy generated by the deformation of the aorta.
对主动脉的过度压迫可能会增加心脏17的工作负荷,因此可以在发电主体11与主动脉壁之间临时放置压力传感器以测定发电主体11对主动脉的压力,避免其对心脏产生不良的影响。Excessive compression of the aorta may increase the workload of the heart 17, so a pressure sensor can be temporarily placed between the power generation body 11 and the wall of the aorta to measure the pressure of the power generation body 11 on the aorta to avoid adverse effects on the heart .
由于调节端23的内部不含有压电材料层和电极层,因此当使用手术缝线或钛夹将调节端23的两侧闭合时,不会对发电主体11造成损害。Since the inside of the adjustment end 23 does not contain piezoelectric material layers and electrode layers, when the two sides of the adjustment end 23 are closed with surgical sutures or titanium clips, no damage will be caused to the power generation body 11 .
图5是本发明实施例中发电主体安装于主动脉上的截面图。以下结合图1和图5来说明本发明的植入式生物能胰岛素泵的工作过程。Fig. 5 is a cross-sectional view of the generator main body installed on the aorta in the embodiment of the present invention. The working process of the implantable bioenergy insulin pump of the present invention will be described below with reference to FIG. 1 and FIG. 5 .
如图1和图5所示,发电主体11环绕于主动脉18。当心脏17收缩时,血流的冲击使主动脉18发生扩张,如图5所示,主动脉壁45会产生一个对发电主体11的压力F,使压电材料层111发生形变,从而在其两端形成电势差并产生电流,电流通过第一电极层112和第二电极层113传导至输出电极14,再通过整流滤波电路12后进入电能存储单元13,电能能存储单元13为微型可充电电池。电能存储单元13再将电能供应给植入式生物能胰岛素泵的血糖监测部20、控制部19、信号发射部16以及注射泵15。当血糖传感器感受到体内的血糖值高于阈值时,控制部19会控制注射泵15通过输注导管151向血液输注适量的胰岛素,同时,信号发射部16会将体内的血糖信息和胰岛素泵的工作状态输出给体外通讯器152。As shown in FIG. 1 and FIG. 5 , the power generating body 11 surrounds the aorta 18 . When the heart 17 contracts, the impact of the blood flow causes the aorta 18 to expand. As shown in FIG. The two ends form a potential difference and generate a current, and the current is conducted to the output electrode 14 through the first electrode layer 112 and the second electrode layer 113, and then enters the electric energy storage unit 13 after passing through the rectification and filtering circuit 12, and the electric energy storage unit 13 is a miniature rechargeable battery . The electric energy storage unit 13 then supplies electric energy to the blood glucose monitoring part 20 , the control part 19 , the signal transmitting part 16 and the injection pump 15 of the implantable bioenergy insulin pump. When the blood glucose sensor senses that the blood glucose level in the body is higher than the threshold, the control unit 19 will control the injection pump 15 to infuse an appropriate amount of insulin into the blood through the infusion catheter 151. The working status is output to the external communicator 152.
图7是本发明植入式生物能胰岛素泵的实施例的电路示意图,如图7所示,发电主体11与整流滤波电路12相连接,发电主体11产生的电能经过整流滤波电路12后对电能存储单元13进行充电,电能存储单元13用于为用电器即本实施例中的血糖监测部、控制部、信号发射部以及注射泵供电。Fig. 7 is a schematic circuit diagram of an embodiment of the implantable bioenergy insulin pump of the present invention. As shown in Fig. 7, the power generation main body 11 is connected with the rectification and filtering circuit 12, and the electric energy generated by the power generation main body 11 passes through the rectification and filtering circuit 12 and is converted to the electric energy. The storage unit 13 is charged, and the electric energy storage unit 13 is used to supply power to electrical appliances, namely the blood glucose monitoring unit, the control unit, the signal transmitting unit and the injection pump in this embodiment.
<实施例二><Example 2>
在本实施例中,植入式生物能胰岛素泵的血糖监测部、控制部、信号发射部、注射泵、发电主体的形状以及调节端的设置与实施例一相同,区别之处在于本实施例中,发电主体的压电材料层采用纳米级压电陶瓷材料。In this embodiment, the shape of the blood glucose monitoring part, the control part, the signal transmitting part, the injection pump, the power generation body and the setting of the adjustment end of the implantable bioenergy insulin pump are the same as in the first embodiment, the difference is that in this embodiment , the piezoelectric material layer of the power generation body adopts nanoscale piezoelectric ceramic materials.
另外一个区别之处在于,本实施例中调节端23采用钛夹固定。在固定的同时使用微型压力传感器检测发电主体对主动脉外壁的压力,缓慢收紧卡齿,直到该压力达到120-140mmHg。Another difference is that in this embodiment, the adjustment end 23 is fixed by a titanium clip. While being fixed, use a miniature pressure sensor to detect the pressure of the generator body on the outer wall of the aorta, and slowly tighten the teeth until the pressure reaches 120-140mmHg.
<实施例三><Example Three>
在本实施例中,生物能胰岛素泵的血糖监测部、控制部、信号发射部、注射泵、发电主体的形状以及调节端的设置与实施例一相同,区别之处在于本实施例中,发电主体的压电材料层采用压电聚合物,并且调节端采用粘合剂粘合的方式进行固定。在固定的同时使用微型压力传感器检测发电主体对主动脉外壁的压力,缓慢收紧卡齿,直到该压力达到120-140mmHg。In this embodiment, the blood glucose monitoring part, control part, signal transmitting part, syringe pump, and the shape of the power generation body and the setting of the adjustment end of the bioenergy insulin pump are the same as in the first embodiment, the difference is that in this embodiment, the power generation body The piezoelectric material layer is made of piezoelectric polymer, and the adjustment end is fixed by adhesive bonding. While being fixed, use a miniature pressure sensor to detect the pressure of the generator body on the outer wall of the aorta, and slowly tighten the teeth until the pressure reaches 120-140mmHg.
<实施例四><Example 4>
在本实施例中,生物能胰岛素泵的血糖监测部、控制部、信号发射部、注射泵、发电主体的形状以及调节端的设置与实施例一相同,区别之处在于本实施例中,如图6所示,调节端61的一端为单排的卡齿,齿尖平滑且面向发电主体的外侧,以防止齿尖损伤心脏或主动脉等人体组织。调节端61的另一端为卡槽,卡槽的内部一侧具有与卡齿相配合的齿槽,另一侧为平面。当将发电部固定于主动脉外壁时,缓慢的将卡齿插入卡槽,同时使用微型压力传感器检测发电主体对主动脉外壁的压力,缓慢收紧卡齿,直到该压力达到120-140mmHg。In this embodiment, the shape of the blood glucose monitoring part, control part, signal transmitting part, syringe pump, power generation main body and the setting of the adjustment end of the bioenergy insulin pump are the same as in the first embodiment, the difference lies in this embodiment, as shown in Fig. As shown in 6, one end of the adjustment end 61 is a single row of locking teeth, and the tip of the tooth is smooth and faces the outside of the main body of the generator, so as to prevent the tip of the tooth from damaging human tissues such as the heart or the aorta. The other end of the adjustment end 61 is a card slot, and one side of the card slot has a tooth groove matching with the card teeth, and the other side is a plane. When fixing the generating part on the outer wall of the aorta, slowly insert the locking teeth into the slot, and at the same time use the micro pressure sensor to detect the pressure of the generating body on the outer wall of the aorta, and slowly tighten the locking teeth until the pressure reaches 120-140mmHg.
当然本发明的植入式生物能胰岛素泵并不限于以上实施例中所描述的设计,其压电材料层、电极层以封装层均可以采用各种现有的适宜材料制成。Of course, the implantable bioenergy insulin pump of the present invention is not limited to the designs described in the above embodiments, and its piezoelectric material layer, electrode layer and packaging layer can be made of various existing suitable materials.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310731830.7A CN104740713A (en) | 2013-12-26 | 2013-12-26 | Implantable biological energy insulin pump |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310731830.7A CN104740713A (en) | 2013-12-26 | 2013-12-26 | Implantable biological energy insulin pump |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104740713A true CN104740713A (en) | 2015-07-01 |
Family
ID=53581319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310731830.7A Pending CN104740713A (en) | 2013-12-26 | 2013-12-26 | Implantable biological energy insulin pump |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104740713A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108671370A (en) * | 2018-06-20 | 2018-10-19 | 南京林业大学 | The insulin closed loop controlled release mechanisms of biological fuel cell driving |
| WO2023236532A1 (en) * | 2022-06-08 | 2023-12-14 | 深圳清华大学研究院 | Micro power generation apparatus based on blood vessel pulsation, and implantable micro device |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020013545A1 (en) * | 1998-01-29 | 2002-01-31 | David Soltanpour | Synthetic muscle based diaphragm pump apparatuses |
| JP2002085556A (en) * | 2000-07-14 | 2002-03-26 | Nikkiso Co Ltd | Implantable artificial pancreas device |
| US20080132881A1 (en) * | 2005-11-09 | 2008-06-05 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Injectable controlled release fluid delivery system |
| US20100295419A1 (en) * | 2009-05-19 | 2010-11-25 | Yasuhisa Fujii | Electric power device, electric power generation method, and production method of electric power device |
| US20100298720A1 (en) * | 2009-04-16 | 2010-11-25 | Potkay Joseph Allen | In Situ Energy Harvesting Systems for Implanted Medical Devices |
| CN102197304A (en) * | 2008-11-04 | 2011-09-21 | 松下电器产业株式会社 | Measurement device, insulin injection device, measurement method, control method and program for insulin injection device |
| WO2012011132A1 (en) * | 2010-07-20 | 2012-01-26 | SCUOLA SUPERIORE Dl STUDI UNIVERSITARI E Dl PERFEZIONAMENTO SANT'ANNA | System for controlled administration of a substance from a human-body-implanted infusion device |
| CN203619989U (en) * | 2013-12-26 | 2014-06-04 | 中国人民解放军第二军医大学 | Implanted type bioenergy insulin pump |
-
2013
- 2013-12-26 CN CN201310731830.7A patent/CN104740713A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020013545A1 (en) * | 1998-01-29 | 2002-01-31 | David Soltanpour | Synthetic muscle based diaphragm pump apparatuses |
| JP2002085556A (en) * | 2000-07-14 | 2002-03-26 | Nikkiso Co Ltd | Implantable artificial pancreas device |
| US20080132881A1 (en) * | 2005-11-09 | 2008-06-05 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Injectable controlled release fluid delivery system |
| CN102197304A (en) * | 2008-11-04 | 2011-09-21 | 松下电器产业株式会社 | Measurement device, insulin injection device, measurement method, control method and program for insulin injection device |
| US20100298720A1 (en) * | 2009-04-16 | 2010-11-25 | Potkay Joseph Allen | In Situ Energy Harvesting Systems for Implanted Medical Devices |
| US20100295419A1 (en) * | 2009-05-19 | 2010-11-25 | Yasuhisa Fujii | Electric power device, electric power generation method, and production method of electric power device |
| WO2012011132A1 (en) * | 2010-07-20 | 2012-01-26 | SCUOLA SUPERIORE Dl STUDI UNIVERSITARI E Dl PERFEZIONAMENTO SANT'ANNA | System for controlled administration of a substance from a human-body-implanted infusion device |
| CN203619989U (en) * | 2013-12-26 | 2014-06-04 | 中国人民解放军第二军医大学 | Implanted type bioenergy insulin pump |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108671370A (en) * | 2018-06-20 | 2018-10-19 | 南京林业大学 | The insulin closed loop controlled release mechanisms of biological fuel cell driving |
| WO2023236532A1 (en) * | 2022-06-08 | 2023-12-14 | 深圳清华大学研究院 | Micro power generation apparatus based on blood vessel pulsation, and implantable micro device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070167988A1 (en) | Apparatus and method for supplying power to subcutaneously implanted devices | |
| US20100298720A1 (en) | In Situ Energy Harvesting Systems for Implanted Medical Devices | |
| CN104740773A (en) | Heart generating system | |
| CN104740714B (en) | Implantable self-powered insulin pump | |
| CN111282154A (en) | Intracardiac energy harvesting device and implantable electronic medical device | |
| CN203816091U (en) | Bioenergy cardiac pacemaker | |
| CN203619989U (en) | Implanted type bioenergy insulin pump | |
| CN104740768B (en) | Self energizing pacemaker | |
| CN104740713A (en) | Implantable biological energy insulin pump | |
| CN203886012U (en) | Power generation system for heart | |
| CN203693604U (en) | Implantable bio-energy blood glucose monitor | |
| Zitouni et al. | Piezoelectric energy harvesting for wearable and implantable devices | |
| CN203693839U (en) | Bio-energy electronic cochlea | |
| CN203620083U (en) | Bioenergy bladder pacemaker | |
| CN104739427A (en) | Implantable biological energy blood glucose monitor | |
| CN104740762B (en) | Self energizing brain pacemaker | |
| CN104740772A (en) | Bioenergy cardiac pacemaker | |
| CN203620084U (en) | Bioenergy brain pacemaker | |
| CN204073104U (en) | Bioenergy Ventricular resynchronization cardioverter defibrillators | |
| CN104739547B (en) | Bioenergy cochlear implant | |
| CN203693899U (en) | Bio-energy electronic retina | |
| CN104739578A (en) | Biological-energy electronic retina | |
| CN104740759B (en) | Heart nanometer generating system | |
| CN203989258U (en) | Implanted self energizing insulin pump | |
| CN203694407U (en) | Implantable biological energy heart cardioversion defibrillator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150701 |